Solid Potential For Gilead To Beat Estimates And Raise Guidance: Here's How

By: via Benzinga
Citi expects Gilead Sciences, Inc. (NASDAQ: GILD) to report a beat and raise second-quarter, as it sees about $280 million upside to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.